{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:57Z","timestamp":1787027817453,"version":"build-2736575974"},"reference-count":106,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Youth Science Foundation Project","award":["82204159"],"award-info":[{"award-number":["82204159"]}]},{"name":"National Youth Science Foundation Project","award":["cstc2021jcyj-bshX0220"],"award-info":[{"award-number":["cstc2021jcyj-bshX0220"]}]},{"name":"Postdoctoral Fund project of Chongqing","award":["82204159"],"award-info":[{"award-number":["82204159"]}]},{"name":"Postdoctoral Fund project of Chongqing","award":["cstc2021jcyj-bshX0220"],"award-info":[{"award-number":["cstc2021jcyj-bshX0220"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Increasing evidence confirms that tumor microenvironment (TME) can influence tumor progression and treatment, but TME is still understudied in adrenocortical carcinoma (ACC). In this study, we first scored TME using the xCell algorithm, then defined genes associated with TME, and then used consensus unsupervised clustering analysis to construct TME-related subtypes. Meanwhile, weighted gene co-expression network analysis was used to identify modules correlated with TME-related subtypes. Ultimately, the LASSO-Cox approach was used to establish a TME-related signature. The results showed that TME-related scores in ACC may not correlate with clinical features but do promote a better overall survival. Patients were classified into two TME-related subtypes. Subtype 2 had more immune signaling features, higher expression of immune checkpoints and MHC molecules, no CTNNB1 mutations, higher infiltration of macrophages and endothelial cells, lower tumor immune dysfunction and exclusion scores, and higher immunophenoscore, suggesting that subtype 2 may be more sensitive to immunotherapy. 231 modular genes highly relevant to TME-related subtypes were identified, and a 7-gene TME-related signature that independently predicted patient prognosis was established. Our study revealed an integrated role of TME in ACC and helped to identify those patients who really responded to immunotherapy, while providing new strategies on risk management and prognosis prediction.<\/jats:p>","DOI":"10.3390\/cells12050755","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T04:13:16Z","timestamp":1677471196000},"page":"755","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Characteristics of Tumor Microenvironment Predict Survival and Response to Immunotherapy in Adrenocortical Carcinomas"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-477X","authenticated-orcid":false,"given":"Guichuan","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-1053","authenticated-orcid":false,"given":"Hui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielian","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"vii131","DOI":"10.1093\/annonc\/mds231","article-title":"Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Berruti","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.soc.2015.08.011","article-title":"Surgical Management of Adrenocortical Carcinoma: An Evidence-Based Approach","volume":"25","author":"Datta","year":"2016","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9362108","DOI":"10.1155\/2018\/9362108","article-title":"Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis","volume":"2018","author":"Tang","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1590\/s1677-5538.ibju.2017.0095","article-title":"Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: Are we offering the best?","volume":"43","author":"Srougi","year":"2017","journal-title":"Int. Braz. J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Karwacka, I., Obo\u0142o\u0144czyk, \u0141., Kaniuka-Jakubowska, S., and Sworczak, K. (2021). The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020098"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11912-019-0773-7","article-title":"Management of Adrenocortical Carcinoma","volume":"21","author":"Jasim","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1056\/NEJMe078087","article-title":"Adjuvant mitotane therapy of adrenal cancer-use and controversy","volume":"356","author":"Schteingart","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/ERC-15-0452","article-title":"Future directions in the diagnosis and medical treatment of adrenocortical carcinoma","volume":"23","author":"Creemers","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17588359211038409","DOI":"10.1177\/17588359211038409","article-title":"Management of adrenocortical carcinoma: Are we making progress?","volume":"13","author":"Kiesewetter","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): An European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Borget","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: Proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00423-010-0698-y","article-title":"Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade","volume":"395","author":"Miller","year":"2010","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1210\/js.2018-00197","article-title":"Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era","volume":"2","author":"Mohan","year":"2018","journal-title":"J.Endocr. Soc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101428","DOI":"10.1016\/j.beem.2020.101428","article-title":"Adrenocortical tumorigenesis: Lessons from genetics","volume":"34","author":"Kamilaris","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma-towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3892\/or.2016.4660","article-title":"Role of the tumor microenvironment in tumor progression and the clinical applications (Review)","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1517\/14712598.2012.707184","article-title":"Induced and natural regulatory T cells in human cancer","volume":"12","author":"Whiteside","year":"2012","journal-title":"ExpertOpin. Biol.Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"M111.014647","DOI":"10.1074\/mcp.M111.014647","article-title":"The matrisome: In silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices","volume":"11","author":"Naba","year":"2012","journal-title":"Mol. Cell Proteom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Parise, I.Z.S., Parise, G.A., Noronha, L., Surakhy, M., Woiski, T.D., Silva, D.B., Costa, T.E.B., Del-Valle, M.H.C.P., Komechen, H., and Rosati, R. (2019). The Prognostic Role of CD8+ T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss Score. Cancers, 11.","DOI":"10.3390\/cancers11111730"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1784529","DOI":"10.1080\/2162402X.2020.1784529","article-title":"Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: Results from bioinformatics and real-world data","volume":"9","author":"Tian","year":"2020","journal-title":"Oncoimmunology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kretschmer, M., R\u00fcdiger, D., and Zahler, S. (2021). Mechanical Aspects of Angiogenesis. Cancers, 13.","DOI":"10.3390\/cancers13194987"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12253-017-0259-6","article-title":"Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors","volume":"24","author":"Pereira","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","article-title":"Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djz208","article-title":"Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach","volume":"112","author":"Bareche","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s13402-022-00725-1","article-title":"Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response","volume":"45","author":"Bu","year":"2022","journal-title":"Cell. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"984480","DOI":"10.3389\/fimmu.2022.984480","article-title":"Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"838374","DOI":"10.3389\/fimmu.2022.838374","article-title":"Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_36","first-page":"6737241","article-title":"Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy","volume":"2022","author":"Wang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Katz, S., Irizarry, R.A., Lin, X., Tripputi, M., and Porter, M.W. (2006). A summarization approach for Affymetrix GeneChip data using a reference training set from a large, biologically diverse database. BMC Bioinform., 7.","DOI":"10.1186\/1471-2105-7-464"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: A bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: Digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: A Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1038\/srep06207","article-title":"Critical limitations of consensus clustering in class discovery","volume":"4","author":"Michailidis","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hanzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: An R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Langfelder, P., and Horvath, S. (2008). WGCNA: An R package for weighted correlation network analysis. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-559"},{"key":"ref_52","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/1078-0432.CCR-19-1321","article-title":"Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response","volume":"26","author":"Garris","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"597878","DOI":"10.3389\/fendo.2020.597878","article-title":"Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma","volume":"11","author":"Chifu","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"953530","DOI":"10.3389\/fimmu.2022.953530","article-title":"Activation and regulation mechanisms of NOD-like receptors based on structural biology","volume":"13","author":"Ohto","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like Receptors and the Control of Immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4436646","DOI":"10.1155\/2022\/4436646","article-title":"Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer","volume":"2022","author":"Ping","year":"2022","journal-title":"BioMed Res. Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E421","DOI":"10.1210\/jc.2010-1100","article-title":"Abrogation of TLR4 and CD14 expression and signaling in human adrenocortical tumors","volume":"95","author":"Kanczkowski","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08830185.2021.1921175","article-title":"Innate immunity: Trained immunity and innate allorecognition against the allograft","volume":"41","author":"Mirzakhani","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41423-019-0216-2","article-title":"The innate immune response to allotransplants: Mechanisms and therapeutic potentials","volume":"16","author":"Ochando","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"948353","DOI":"10.3389\/fgene.2022.948353","article-title":"Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Front. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: Teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s42003-022-04075-4","article-title":"Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors","volume":"5","author":"Sanders","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"686907","DOI":"10.3389\/fcell.2021.686907","article-title":"Development and Validation of an IL6\/JAK\/STAT3-Related Gene Signature to Predict Overall Survival in Clear Cell Renal Cell Carcinoma","volume":"9","author":"Zhan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Schulze, A., Oshi, M., Endo, I., and Takabe, K. (2020). MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218127"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"828684","DOI":"10.3389\/fonc.2022.828684","article-title":"Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1","volume":"12","author":"Bukhari","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-015-0080-3","article-title":"Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma","volume":"5","author":"Bussey","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-19-1063","article-title":"Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Cancer Growth","volume":"19","author":"Trotta","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","article-title":"The broken cycle: E2F dysfunction in cancer","volume":"19","author":"Kent","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_74","first-page":"2789","article-title":"EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression","volume":"25","author":"Drelon","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1073\/pnas.1512832112","article-title":"STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity","volume":"112","author":"Demaria","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/ERC-12-0217","article-title":"Interferon-\u03b2 is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane","volume":"20","author":"Vitale","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e2002054","DOI":"10.1002\/adma.202002054","article-title":"Engineering Macrophages for Cancer Immunotherapy and Drug Delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1111\/jcmm.16936","article-title":"Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma","volume":"25","author":"Baechle","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Guan, Y., Yue, S., Chen, Y., Pan, Y., An, L., Du, H., and Liang, C. (2022). Molecular Cluster Mining of Adrenocortical Carcinoma via Multi-Omics Data Analysis Aids Precise Clinical Therapy. Cells, 11.","DOI":"10.3390\/cells11233784"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Shimada, H., Yamazaki, Y., Sugawara, A., Sasano, H., and Nakamura, Y. (2021). Molecular Mechanisms of Functional Adrenocortical Adenoma and Carcinoma: Genetic Characterization and Intracellular Signaling Pathway. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080892"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: A children\u2019s oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Fassnacht","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"\u03b2-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Lu, Q., Nie, R., Luo, J., Wang, X., and You, L. (2023). Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling. Biomolecules, 13.","DOI":"10.3390\/biom13010104"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3322\/caac.21596","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Xu, F., Guan, Y., Zhang, P., Xue, L., Ma, Y., Gao, M., Chong, T., and Ren, B.C. (2022). Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-01017-3"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy","volume":"359","author":"Xu","year":"2018","journal-title":"Science"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.critrevonc.2017.06.001","article-title":"Biomarkers of response to PD-1\/PD-L1 inhibition","volume":"116","author":"MalekiVareki","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: Recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: Clinical implications and future considerations","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e100926","DOI":"10.15252\/embj.2018100926","article-title":"Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis","volume":"38","author":"Fisch","year":"2019","journal-title":"EMBO J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: Mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1080\/15548627.2021.1872241","article-title":"Tumor heterogeneity in autophagy-dependent ferroptosis","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"22269","DOI":"10.1073\/pnas.1912700116","article-title":"Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis","volume":"116","author":"Belavgeni","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrm3139","article-title":"Autophagy: TFEB perfects multitasking","volume":"12","author":"David","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"937367","DOI":"10.3389\/fendo.2022.937367","article-title":"Modulation of Autophagy in Adrenal Tumors","volume":"13","author":"Sousa","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.7150\/ijms.60261","article-title":"The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma","volume":"18","author":"Ma","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e1577126","DOI":"10.1080\/2162402X.2019.1577126","article-title":"CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation","volume":"8","author":"Wang","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4161\/cbt.10.12.14009","article-title":"Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors","volume":"10","author":"Lassoued","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Pereira, S.S., Oliveira, S., Monteiro, M.P., and Pignatelli, D. (2021). Angiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors. Cancers, 13.","DOI":"10.3390\/cancers13051030"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"767070","DOI":"10.3389\/fimmu.2021.767070","article-title":"Single-Cell Transcriptome Analysis Reveals RGS1 as a New Marker and Promoting Factor for T-Cell Exhaustion in Multiple Cancers","volume":"12","author":"Bai","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/5\/755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:43:32Z","timestamp":1760121812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/5\/755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":106,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["cells12050755"],"URL":"https:\/\/doi.org\/10.3390\/cells12050755","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}